How to Lower Your Farxiga Costs: Insurance, Generics & Canadian Pharmacy Options

If you are an American living on Social Security, Medicare, disability income, or a fixed retirement budget, paying for Farxiga every month can feel overwhelming. You may be following your doctor’s advice, checking your insurance, and comparing pharmacy prices, yet still facing a bill that does not fit your monthly budget. The average retail price for a 90-day supply of Farxiga 10 mg is $1,115.06 without insurance.

Farxiga’s high-cost stems from patent protection on brand-name drugs, delayed generic competition, and a U.S. pricing system with no government ceiling, leaving 31.9 million Americans with diabetes with no choice but to pay for brand-name Farxiga until generic versions were approved in April 2026.

In April 2026, the first generic versions of dapagliflozin were approved, giving Americans another treatment option. While many people expect generic drugs to cost less, that is not always the case. In some cases, generic dapagliflozin may cost about $662.05, compared to about $579.69 for brand name Farxiga. If you do not have insurance or your coverage is limited, the cost of either medication can still be difficult to afford.

For many Americans, especially those budgeting month to month, switching to generic drugs does not automatically mean meaningful savings. If you are frustrated by that reality, you are not alone.

To understand why the price feels so high, it helps to look first at what Farxiga does, how it is priced in the U.S., and why the usual cost-saving options do not always work as expected.

This guide explains why Farxiga costs so much in the U.S. and why many Americans struggle to afford it, then shows how licensed Canadian online pharmacy pricing may offer a more affordable way to access Farxiga or dapagliflozin with a valid prescription.

Before comparing prices or alternatives, it is useful to start with what Farxiga is prescribed for and why doctors recommend it for certain patients.

What Is Farxiga?

Farxiga (dapagliflozin) is a prescription medication that is mainly used alongside diet and exercise to help treat type 2 diabetes and manage blood sugar levels.

It belongs to a class of medications called SGLT2 inhibitors (sodium-glucose cotransporter-2 inhibitors). SGLT2 inhibitor cost in the U.S. is among the highest of any diabetes drug class, making Farxiga one of the more expensive medications in its category.

What Makes Farxiga Different?

Farxiga does more than lower blood sugar. By helping the body remove excess sugar, salt, and water through urine, it can also help reduce the risk of certain heart and kidney complications. This broader range of benefits has made it an important treatment option not only for people with type 2 diabetes but also for some individuals with heart failure or chronic kidney disease.

Once you understand why Farxiga is prescribed, the next question is usually the one that matters most at the pharmacy counter: how much will it cost?

What Is the Farxiga Price in the U.S. Today?

Without insurance or a prescription savings program, the cost of brand-name Farxiga can create a significant financial burden for many Americans paying out of pocket.

The Farxiga monthly cost for a 30-day supply of both the 5 mg and 10 mg doses runs around $579.69  at U.S. pharmacies, or approximately $6,956 per year. The 10 mg strength is the dose most patients are prescribed for long-term management.

For someone managing type 2 diabetes, heart failure, or chronic kidney disease, the cost of Farxiga can add extra pressure to everyday expenses. It can force patients to make difficult choices they should not have to make.

For many patients, these prices are simply too high. Before looking at Canadian pharmacy pricing, it is worth reviewing how insurance may affect your out-of-pocket cost and why coverage does not always make Farxiga affordable.

Farxiga Insurance Coverage: Medicare Part D and Commercial Plan Costs

Farxiga is covered by most commercial insurance plans, but coverage alone doesn’t always mean affordable. Many plans require prior authorization for Farxiga before they’ll cover it, meaning your doctor must first submit documentation justifying your need for the medication before approval is granted. Others enforce step therapy for Farxiga, requiring you to try and fail on a cheaper alternative before your plan will approve coverage.

Even for Medicare beneficiaries, out-of-pocket costs can add up. Research examining Medicare Part D Farxiga coverage found that despite widespread plan inclusion, you could still face significant annual out-of-pocket costs for this medication. That financial gap hits hardest for older Americans on fixed incomes who depend on Farxiga every single day to protect their heart or kidneys.

Cost is only one part of the decision. The next question many patients ask is whether Farxiga’s health benefits justify the price they are being asked to pay.

Is Farxiga Worth the Cost?

Yes, if you can actually afford it. Two independent studies confirm that dapagliflozin delivers 0.46 to 0.63 additional quality-adjusted life-years, cuts hospitalizations, and lands a cost-effectiveness ratio between $68,300 and $83,650 per QALY, both well under the U.S. accepted $100,000 threshold. For many people, the medication can be clinically valuable. The problem is that value does not help if the price keeps it out of reach. In the U.S., high copays, complicated prior authorizations, and inconsistent insurance coverage can mean many Americans never get the chance to benefit from a drug that could support their long-term health.

If Farxiga can be clinically valuable, the natural follow-up question is why the same medication can still feel financially out of reach for so many Americans.

Why Is Farxiga So Expensive?

The U.S. prescription drug market is characterized by high prices due to monopoly protections, patent systems, and limited price regulation, which can make medications like Farxiga expensive for patients compared to affordability in many healthcare systems globally.

Understanding what drives these costs can help explain why accessing affordable type-2 diabetes treatment has become so challenging for American patients.

Lack of Price Regulation Allows Manufacturers to Set High Prices

One of the biggest reasons Farxiga costs so much in the U.S. is the absence of strong government price regulation. Unlike in Canada, where drug prices are more tightly regulated, the U.S. system generally gives manufacturers far more pricing flexibility. As a result, American patients may pay much more for the same medication, especially when deductibles, copays, or limited coverage shift more of the cost onto you.

Patent Protection Limits Competition and Keeps Prices High

Farxiga (dapagliflozin) was protected by multiple U.S. patents that blocked generic competition for many years. The drug’s primary compound patent expired in April 2026, and the U.S. food and drug regulator has since approved the first generic Farxiga versions which could mean lower costs for you going forward. Patent and exclusivity protections can delay generic entry, which may contribute to higher brand-name drug prices while those protections remain in effect.

Research and Development Costs Are Passed Directly to Patients

Developing Farxiga required significant investment in laboratory research, clinical trials, and regulatory approvals. While these costs are real, the lack of price regulation in the U.S. means manufacturers can recoup their R&D drug costs by charging American patients premium prices, often several times what patients in other countries pay for the same medication.

Marketing and Branding Add to Your Out-of-Pocket Costs

Like many brand-name prescription medications, Farxiga has been promoted to healthcare professionals and consumers through educational and marketing campaigns. Brand-name drug manufacturers may invest heavily in pharmaceutical marketing expenses including advertising, patient support programs, and promotional activities to increase awareness of their products. These expenses are part of the overall costs associated with bringing and maintaining a branded medication in the market, which can contribute to higher prices compared with generic alternatives when available.

The U.S. Insurance System Often Fails to Lower Patient Costs

Even with insurance, many Americans face high out-of-pocket costs for Farxiga. The complex network of insurance plans, pharmacy benefit managers (PBMs), and behind-the-scenes rebate negotiations rarely results in meaningful out-of-pocket savings for patients like you. High deductibles, restrictive formularies, and tiered pricing can leave you paying hundreds of dollars, even with “good” insurance coverage.

The bottom line: because of these factors, you’re paying significantly more for Farxiga than patients in countries with regulated drug pricing for the exact same medication. The medication is the same, but the price tag isn’t, and that’s a direct result of policy choices, not market necessity.

Generic Farxiga: Patent Expiration and What It Means for Your Costs

Now that generic dapagliflozin has entered the market, many patients want to know whether it automatically means lower costs. The answer is: not always. For many years, patent and regulatory exclusivity protections limited generic competition for Farxiga in the United States. After key protections expired, the U.S. food and drug regulator approved the first generic versions of dapagliflozin in April 2026. Increased generic competition may help lower prices over time, although actual savings can vary depending on pharmacy pricing, insurance coverage, and product availability.

Generic dapagliflozin, the active ingredient in Farxiga, is now available in some markets at a lower price than the brand-name version, which may help reduce treatment costs. However, the availability and cost of generic medications can vary by pharmacy, insurance plan, and location.

While generic competition often leads to lower prices over time, some patients may still face significant out-of-pocket costs depending on their prescription drug coverage, deductibles, and copay requirements.

If the U.S. generic price is still too high, comparing options through services such as DoctorSolve.com, which helps patients access medications from licensed Canadian pharmacies, may be another practical step.

How to Get Dapagliflozin for About $1.44 Per Pill From Licensed Canadian and International Pharmacies

Through a trusted prescription referral service like Doctorsolve, you can get 90 Dapagliflozin 10 mg tablets for $130, compared to a typical U.S. price of $1,986 at U.S. pharmacies. That may represent approximately 93.5% in potential savings, or about $7,500 per year compared with typical U.S. prices. If you take dapagliflozin long term and live on a fixed income, those savings can make it easier to keep treatment in your monthly budget.

You can buy Dapagliflozin for as low as $1.44 per tablet online from a Canadian pharmacy through Doctorsolve.com

Once you have compared the U.S. brand price, your insurance coverage, and the generic option, the next step is to look at Canadian pharmacy pricing as one possible way to reduce your monthly cost.

How to Buy Farxiga from Canada Through a Licensed Online Pharmacy

If U.S. pharmacy prices are too high for your budget, licensed Canadian pharmacy options may be one practical choice to compare. Canadian pricing regulations and controlled markups can make Farxiga more affordable than typical U.S. retail prices, while upfront cash pricing can help you understand the total cost before you order.

Through international pharmacy pricing available at a trusted referral service like Doctorsolve.com, you can get Farxiga 10 mg for 84 days for about $220, compared to a typical U.S. price of $1,623 (7) at U.S. pharmacies. That difference may translate to approximately $501 per month, or about $3,580.56 per year, in potential savings compared with typical U.S. prices. For someone living on a fixed monthly income, that difference may help cover groceries, utilities, transportation, or other prescription costs without skipping doses.

You can buy Farxiga for as low as $2.62 per tablet online from a Canadian pharmacy through Doctorsolve.com

Key Takeaways -Farxiga’s high U.S. price stems from a lack of government price regulation, patent protections that blocked generic competition until 2026, and the fact that R&D and marketing costs are passed directly to patients. Insurance often doesn’t help much either, since high deductibles, restrictive formularies, and PBM rebate negotiations can still leave patients paying hundreds out of pocket. As a result, Americans pay far more than patients in countries with regulated pricing — though licensed Canadian pharmacies can offer significant, consistent savings.

Is Buying Farxiga From a Canadian Online Pharmacy Safe?

If you are ordering from the United States, it is normal to have questions about safety, prescriptions, and pharmacy legitimacy. Buying Farxiga from a Canadian online pharmacy can be safe when you choose a licensed pharmacy that requires a valid prescription, follows applicable pharmacy regulations, and clearly explains where the medication is dispensed from before you order.

Health Canada and the U.S. food and drug regulator both recommend purchasing prescription medications only from properly licensed pharmacies and provide access to pharmacy professionals who can answer questions about your treatment.

As with any online purchase, it is important to verify that the pharmacy is legitimate and operates in accordance with recognized standards. Reputable online pharmacies are transparent about their licensing information, require a valid prescription for prescription-only medications, provide clear contact information, and may also belong to recognized industry organizations such as the Canadian International Pharmacy Association (CIPA), which has member standards designed to promote safe pharmacy practices.

Before ordering Farxiga online, take a few moments to review the pharmacy’s licensing information, confirm that a valid prescription is required, look for recognized pharmacy credentials such as CIPA membership where applicable, and make sure pharmacist support is available if you have questions.

Farxiga Alternatives: Are There Cheaper Options That Work Just as Well?

Yes, there are cheaper alternatives to Farxiga. Depending on your condition, treatment goals, and what your doctor recommends, you may have some solid alternatives worth exploring. Here are the most common ones:

Jardiance (empagliflozin)

Jardiance (empagliflozin) is an SGLT2 inhibitor that helps lower blood sugar by removing excess glucose through the urine. When comparing Jardiance vs Farxiga cost, both medications work similarly for type 2 diabetes, heart health, and kidney function but Jardiance is often available at a lower price through Canadian pharmacies.

If your healthcare provider prescribes Jardiance, ordering through a trusted prescription referral service like Doctorsolve.com may significantly reduce your medication costs. A 56-day supply of Jardiance 10 mg is available for about $185, compared with a typical U.S. retail price of $839—a savings of approximately 78%. For patients taking Jardiance year-round, that could amount to roughly $4,314 in annual savings.

You can buy Jardiance for as low as $3.30 per tablet online from a Canadian pharmacy through Doctorsolve.com

Invokana (canagliflozin)

Invokana (canagliflozin) is a prescription medication that helps manage type 2 diabetes and may reduce the risk of certain kidney and cardiovascular complications. When weighing Invokana vs Farxiga cost, both belong to the same drug class and are commonly prescribed for patients who need benefits beyond blood sugar control and Invokana may be the more affordable option depending on your pharmacy.

Patients looking to lower their prescription costs may also find meaningful savings on Invokana through Doctorsolve.com. A 30-day supply of Invokana 100 mg costs about $159, versus a typical U.S. retail price of $661.76. Over the course of a year, eligible patients could save approximately $6,712, making it a cost-effective option for long-term treatment.

You can buy Invokana for as low as $5.30 per tablet online from a Canadian pharmacy through Doctorsolve.com

Key Differences at a Glance

Category	Best Choice
Heart Failure Evidence	Farxiga and Jardiance
Cardiovascular Mortality Evidence	Jardiance
Kidney Disease Benefits	Farxiga and Invokana
Largest A1C Reduction	Invokana
Most Favorable Safety Profile	Farxiga and Jardiance
Only Generic Available (U.S.)	Farxiga
Lowest Brand Cost	Farxiga and Jardiance (approximately equal)

Strategies to Lower Your Farxiga Costs

By this point, you have several possible paths to compare. The best approach is usually to review them in order, starting with your insurance and then looking at savings programs, pharmacy pricing, generics, Canadian pharmacy options, and doctor-approved alternatives.

Farxiga Coupon, Patient Assistance Programs & Manufacturer Discounts

A patient assistance program for Farxiga and manufacturer coupons are designed to help reduce your out-of-pocket expenses. However, these programs are often unreliable for long-term savings, especially if you are on Medicare or do not meet program eligibility rules. They may have strict criteria based on income level, insurance status, or citizenship. Coupons may also expire, be discontinued without notice, or only provide temporary discounts that leave you paying full price later.

Insurance Navigation

Insurance coverage can lower your cost for Farxiga, but plan details vary widely. Even with insurance, you may face high deductibles, co-pays, prior authorization, step therapy, or find that Farxiga is not covered under your specific plan. If you are on Medicare Part D, your deductible, formulary tier, and preferred pharmacy network can change from year to year, which can make monthly costs hard to predict.

Compare Pharmacy Options

Pharmacy prices for the same medication can vary, and comparing local and online pharmacy options may help you find slightly better deals. However, even the lowest U.S. pharmacy prices are often still unaffordable for many patients due to the lack of price regulation.

After reviewing the major cost drivers and savings options, the next step is to turn those ideas into a practical plan you can discuss with your healthcare provider.

Next Steps: Talk to Your Doctor, Check Coverage, and Lower Farxiga Costs

Farxiga costs can vary depending on your insurance coverage, pharmacy, and eligibility for savings programs. While factors such as patent protections and healthcare pricing policies can influence the medication’s cost, there are several practical steps that may help reduce what you pay.

1. Review your insurance coverage: Check whether Farxiga is covered by your plan, what tier it falls under, and whether prior authorization or step therapy requirements apply.
2. Ask your prescriber about therapeutic alternatives: Depending on your medical history and treatment goals, other medications in the same class or different drug classes may be appropriate options.
3. Compare prices across pharmacies: Prescription drug prices can vary substantially between retail, independent, specialty, and mail-order pharmacies and mail-order pharmacy savings can be especially significant for long-term medications like Farxiga.
4. Ask about manufacturer or third-party savings programs: Some patients may qualify for copay assistance, discount programs, or patient support resources depending on their insurance status and eligibility.
5. Consider a 90-day prescription: Many insurance plans offer lower per-tablet costs when you fill a 90-day supply instead of 30 days.
6.  Review your prescription benefits annually: Formularies, deductibles, copays, and preferred pharmacy networks can change from year to year, which may affect your medication costs.

Frequently Asked Questions

What is a cheaper alternative to Farxiga?

The cheaper alternatives to Farxiga are Jardiance and Invokana. These medications work similarly to Farxiga and may be available at lower prices through DoctorSolve.com, which helps patients access prescription medications from licensed Canadian pharmacies. Jardiance costs about $3.30 per tablet, and Invokana costs about $5.30 per tablet. Both may help reduce prescription costs compared to typical U.S. pharmacy prices. Always consult your doctor before switching medications.

Is There a Farxiga Copay Card, Coupon, or any Discount?

Yes. Some patients may qualify for a Farxiga coupon, a Farxiga savings card, or pharmacy discount programs that can meaningfully reduce what you pay at the pharmacy counter. However, eligibility requirements vary, and not everyone will qualify. If you don’t qualify for those discounts, DoctorSolve.com can help you access prescription medications from licensed Canadian pharmacies at more affordable prices.

Does Dosage Strength Affect Cost?

Yes, It can. In the U.S., prescription drug prices can vary significantly depending on the pharmacy, insurance plan, and whether you’re purchasing the 2.5 mg, 5 mg or 10 mg strength. Some patients discover that their out-of-pocket costs remain high regardless of dosage.

By comparison, prices available through licensed Canadian pharmacy services are often more consistent across strengths, with only modest differences between dosage options.

What If My Insurance Doesn’t Cover Farxiga?

You can speak with your healthcare provider to appeal the coverage decision, request prior authorization, or ask about your insurance copay for Farxiga under a different plan tier or alternative treatment. If those options do not lower your costs, DoctorSolve.com may help you access medications from licensed Canadian pharmacies at more affordable prices, potentially reducing your annual prescription expenses compared with typical U.S. retail prices.

Conclusion

If your Farxiga cost is competing with rent, groceries, utilities, or other prescriptions, you are not alone. For Americans managing type 2 diabetes, heart failure, or chronic kidney disease on a fixed income, a long-term prescription can become a serious monthly financial burden.

The good news is that you have real options. Insurance review, savings programs, generic dapagliflozin, therapeutic alternatives, and licensed Canadian pharmacy pricing can each help you make a more informed decision. DoctorSolve.com can help patients access medications from licensed Canadian pharmacies at a fraction of what many U.S. pharmacies charge, without income limits or insurance requirements. If Farxiga feels out of reach financially, talk with your doctor before making any change. Together, you can compare safe options and find a treatment plan that supports your health without forcing you to choose between your medication and the rest of your monthly budget.

References

• Cleveland Clinic. (n.d.). Dapagliflozin tablets. Cleveland Clinic. https://my.clevelandclinic.org/health/drugs/19382-dapagliflozin-tablets
• Faridi, K. F., Dayoub, E. J., Ross, J. S., Dhruva, S. S., Ahmad, T., & Desai, N. R. (2022). Medicare coverage and out-of-pocket costs of quadruple drug therapy for heart failure. JACC: Heart Failure. https://pmc.ncbi.nlm.nih.gov/articles/PMC12293934/
• Food and Drug Administration. (2026, April 14). FDA approves first generic dapagliflozin tablets. U.S. Department of Health and Human Services. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-approves-first-generic-dapagliflozin-tablets
• Food and Drug Administration. (n.d.). Considering an online pharmacy. U.S. Department of Health and Human Services. https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/considering-online-pharmacy
• Health Canada. (n.d.). Safe use of online pharmacies. Government of Canada. https://www.canada.ca/en/health-canada/topics/buying-using-drug-health-products-safely/safe-use-online-pharmacies.html
• National Center for Biotechnology Information. (2023). Dapagliflozin. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK576405/
• National Center for Biotechnology Information. (2024). Sodium-glucose cotransporter-2 inhibitors. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK616489/
• Rajkumar, S. V. (2020). The high cost of prescription drugs: Causes and solutions. Blood Cancer Journal, 10(6), 71. https://pmc.ncbi.nlm.nih.gov/articles/PMC7311400/
• Drugs.com. (n.d.). Dapagliflozin. https://www.drugs.com/dapagliflozin.html
• Drugs.com. (n.d.). Farxiga prices, coupons, copay cards & patient assistance. https://www.drugs.com/price-guide/farxiga
• Drugs.com. (n.d.). Farxiga vs Jardiance comparison. https://www.drugs.com/compare/farxiga-vs-jardiance
• Drugs.com. (n.d.). Farxiga vs Invokana comparison. https://www.drugs.com/compare/farxiga-vs-invokana
• WebMD. (n.d.). Farxiga oral: Uses, side effects, interactions, pictures, warnings & dosing. https://www.webmd.com/drugs/farxiga-dapagliflozin#overdose
• Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Inzucchi, S. E. (2015). Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. New England Journal of Medicine, 373(22), 2117–2128. https://pubmed.ncbi.nlm.nih.gov/28498650/
• Zelniker, T. A., Wiviott, S. D., Raz, I., Im, K., Goodrich, E. L., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Furtado, R. H. M., Bhatt, D. L., Leiter, L. A., McGuire, D. K., Wilding, J. P. H., Sabatine, M. S., & others. (2019). SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes. The Lancet, 393(10166), 31–39. https://pubmed.ncbi.nlm.nih.gov/31569218/
• Kiessling, K. A., Iott, B. E., Pater, J. A., Toscos, T. R., Wagner, S. R., Gottlieb, L. M., & Veinot, T. C. (2022). Health informatics interventions to minimize out-of-pocket medication costs for patients: What providers want. JAMIA Open, 5(1). https://pmc.ncbi.nlm.nih.gov/articles/PMC8903137/
• Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., Cannon, C. P., Capuano, G., Chu, P. L., de Zeeuw, D., Greene, T., Levin, A., Pollock, C., Wheeler, D. C., Yavin, Y., Zhang, H., & Mahaffey, K. W. (2019). Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. New England Journal of Medicine, 380(24), 2295–2306. https://pmc.ncbi.nlm.nih.gov/articles/PMC5620794/
• Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., Bhatt, D. L., Leiter, L. A., McGuire, D. K., Wilding, J. P. H., Ruff, C. T., Gause-Nilsson, I. A. M., Fredriksson, M., Johansson, P. A., Langkilde, A. M., & Sabatine, M. S. (2019). Dapagliflozin and cardiovascular outcomes in type 2 diabetes. New England Journal of Medicine, 380(4), 347–357. https://pmc.ncbi.nlm.nih.gov/articles/PMC7563069/
• McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., Böhm, M., Chiang, C. E., Chopra, V. K., de Boer, R. A., Desai, A. S., Diez, M., Drozdz, J., Dukát, A., Ge, J., & others. (2019). Dapagliflozin in patients with heart failure and reduced ejection fraction. New England Journal of Medicine, 381(21), 1995–2008. https://pmc.ncbi.nlm.nih.gov/articles/PMC8156166/
• Heerspink, H. J. L., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F. F., Mann, J. F. E., McMurray, J. J. V., Lindberg, M., Rossing, P., Sjöström, C. D., Toto, R. D., Langkilde, A. M., & Wheeler, D. C. (2020). Dapagliflozin in patients with chronic kidney disease. New England Journal of Medicine, 383(15), 1436–1446. https://pmc.ncbi.nlm.nih.gov/articles/PMC10397592/
• (2023). PMC10220512. National Library of Medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC10220512/
• (2024). PMC11347552. National Library of Medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC11347552/
• (2024). PMC12765123. National Library of Medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC12765123/
• (2014). PMC4106580. National Library of Medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC4106580/
• (2022). PMC9441277. National Library of Medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC9441277/
• (2022). PMC8920018. National Library of Medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC8920018/
• (2023). PMC9870667. National Library of Medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC9870667/